International Journal of Scientific Research in Dental and Medical Sciences

International Journal of Scientific Research in Dental and Medical Sciences

Evaluating the Level of Homeobox B8 and its Association with Cell Lung Cancer Proliferation Downregulation: A Systematic Review and Meta-analysis

Document Type : Review Article

Authors
Maryam Hassanpour Amnieh 1
Samira Jalalinezhad 2
Mahsa Hajizadeh 3
Majid Hajizadeh 4
1 School of Pharmacy, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
2 Department of Internal Medicine, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran
3 Pathology Department, Johns Hopkins School of Medicine, Baltimore, Maryland, USA
4 Department of Radiology, School of Medicine, Abadan University of Medical Sciences, Abadan, Iran
10.30485/ijsrdms.2024.489316.1619
Abstract
Background and aim: Homeobox family genes have been identified as cancer growth regulators. There is no meta-analysis or comprehensive study on the activity of Homeobox B8 (HOXB8) in lung cancer. The aim of the present study was to Evaluate the level of Homeobox B8 and its association with cell lung cancer proliferation downregulation.
Material and methods: For this systematic review and meta-analysis study, international databases such as MEDLINE (PubMed and Ovid), Web of Science, and Scopus were searched until August 2024 using keywords relevant to the study objectives. STATA/MP. v17 software was used to analyze data.
Results: Five studies were reviewed. high HOXB8 level was a risk factor for unfavorable lung cancer patient overall survival (HR = 3.32; 95% CI 2.78, 3.86; p<0.001). The results suggested a shorter survival time for patients with high Homeobox B8 (HOXB8) expression.
Conclusions: Homeobox B8 (HOXB8) is highly expressed in lung cancer and associated with overall survival.
Keywords
Homeobox
Lung Cancer
Lung Neoplasms

Subjects

[1] Thandra KC, Barsouk A, Saginala K, Aluru JS, Barsouk A. Epidemiology of lung cancer. Contemporary Oncology/Współczesna Onkologia. 2021;25(1):45-52. https://doi.org/10.5114/wo.2021.103829.
[2] Bade BC, Cruz CS. Lung cancer 2020: epidemiology, etiology, and prevention. Clinics in chest medicine. 2020;41(1):1-24.
[3] Shi J, Li D, Liang D, He Y. Epidemiology and prognosis in young lung cancer patients aged under 45 years old in northern China. Scientific Reports. 2021;11(1):6817. https://doi.org/10.1038/s41598-021-86203-4.
[4] Wolf AM, Fontham ET, Church TR, Flowers CR, Guerra CE, LaMonte SJ, et al. Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society. CA: a cancer journal for clinicians. 2018;68(4):250-81. https://doi.org/10.3322/caac.21457.
[5] Kriegsmann M, Haag C, Weis CA, Steinbuss G, Warth A, Zgorzelski C, et al. Deep learning for the classification of small-cell and non-small-cell lung cancer. Cancers. 2020;12(6):1604. https://doi.org/10.3390/cancers12061604.
[6] Zou K, Sun P, Huang H, Zhuo H, Qie R, Xie Y, et al. Etiology of lung cancer: Evidence from epidemiologic studies. Journal of the National Cancer Center. 2022;2(4):216-25. https://doi.org/10.1016/j.jncc.2022.09.004.
[7] Metintaş S. Epidemiology of Lung Cancer. InAirway diseases 2023;1-45. https://doi.org/10.1007/978-3-031-22483-6_57-1.
[8] Suster DI, Mino-Kenudson M. Molecular pathology of primary non-small cell lung cancer. Archives of medical research. 2020;51(8):784-98. https://doi.org/10.1016/j.arcmed.2020.08.004.
[9] Holland PW. Evolution of homeobox genes. Wiley Interdisciplinary Reviews: Developmental Biology. 2013;2(1):31-45. https://doi.org/10.1002/wdev.78.
[10] Ghosh P, Sagerström CG. Developing roles for Hox proteins in hindbrain gene regulatory networks. The International journal of developmental biology. 2018;62(11-12):767-74. https://doi.org/10.1387/ijdb.180141cs.
[11] Zhu B, Zheng Y, Pham AD, Mandal SS, Erdjument-Bromage H, Tempst P, et al. Monoubiquitination of human histone H2B: the factors involved and their roles in HOX gene regulation. Molecular cell. 2005;20(4):601-11. https://doi.org/10.1016/j.molcel.2005.09.025.
[12] Bhatlekar S, Fields JZ, Boman BM. HOX genes and their role in the development of human cancers. Journal of molecular medicine. 2014;92:811-23. https://doi.org/10.1007/s00109-014-1181-y.
[13] de Bessa Garcia SA, Araújo M, Pereira T, Mouta J, Freitas R. HOX genes function in Breast Cancer development. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer. 2020;1873(2):188358. https://doi.org/10.1016/j.bbcan.2020.188358.
[14] Grier DG, Thompson A, Kwasniewska A, McGonigle GJ, Halliday HL, Lappin TR. The pathophysiology of HOX genes and their role in cancer. The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland. 2005;205(2):154-71. https://doi.org/10.1002/path.1710.
[15] Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. bmj. 2021;372. https://doi.org/10.1136/bmj.n71.
[16] Jiang S, Wang T, Han Y, Hida T, Afzal MZ, Zhou C, et al. Downregulation of homeobox B8 in attenuating non-small cell lung cancer cell migration and invasion though the epithelial-mesenchymal transition pathway. Translational Cancer Research. 2024;13(1):413-22. https://doi.org/10.21037/tcr-23-2344.
[17] Yan M, Yin X, Zhang L, Cui Y, Ma X. High expression of HOXB3 predicts poor prognosis and correlates with tumor immunity in lung adenocarcinoma. Molecular Biology Reports. 2022:2607-18. https://doi.org/10.1007/s11033-021-07064-8.
[18] Yan X, Yu H, Liu Y, Hou J, Yang Q, Zhao Y. RETRACTED: miR-27a-3p Functions as a Tumor Suppressor and Regulates Non-small Cell Lung Cancer Cell Proliferation via Targeting HOXB8. Technology in cancer research & treatment. 2019;18:1533033819861971. https://doi.org/10.1177/1533033819861971.
[19] 苏先旭, 张雪淋. HOX 基因与肺癌的发生发展的相互作用. 世界最新医学信息文摘 (电子版). 2014;14(29):166-.
[20] Inamura K, Togashi Y, Okui M, Ninomiya H, Hiramatsu M, Satoh Y, et al. HOXB2 as a novel prognostic indicator for stage I lung adenocarcinomas. Journal of Thoracic Oncology. 2007;2(9):802-7. https://doi.org/10.1097/JTO.0b013e3181461987.
[21] de Bessa Garcia SA, Araújo M, Freitas R. Dataset of HOXB7, HOXB8 and HOXB9 expression profiles in cell lines representative of the breast cancer molecular subtypes Luminal a (MCF7), Luminal b (BT474), HER2+ (SKBR3) and triple-negative (MDA231, MDA468), compared to a model of normal cells (MCF10A). Data in Brief. 2020;30:105572. https://doi.org/10.1016/j.dib.2020.105572.
[22] Lu N, Yin Y, Yao Y, Zhang P. SNHG3/miR‐2682‐5p/HOXB8 promotes cell proliferation and migration in oral squamous cell carcinoma. Oral Diseases. 2021;27(5):1161-70. https://doi.org/10.1111/odi.13656.
[23] Jiang X, Li J, Wang W, Hu Z, Guan C, Zhao Y, Li W, et al. AR-induced ZEB1-AS1 represents poor prognosis in cholangiocarcinoma and facilitates tumor stemness, proliferation and invasion through mediating miR-133b/HOXB8. Aging (Albany NY). 2020;12(2):1237-55. https://doi.org/10.18632/aging.102680.
[24] Ding WJ, Zhou M, Chen MM, Qu CY. HOXB8 promotes tumor metastasis and the epithelial–mesenchymal transition via ZEB2 targets in gastric cancer. Journal of cancer research and clinical oncology. 2017;143:385-97. https://doi.org/10.1007/s00432-016-2283-4.
[25] Guo J, Zhang T, Dou D. Knockdown of HOXB8 inhibits tumor growth and metastasis by the inactivation of Wnt/β-catenin signaling pathway in osteosarcoma. European Journal of Pharmacology. 2019;854:22-7. https://doi.org/10.1016/j.ejphar.2019.04.004.
[26] Ying Y, Wang Y, Huang X, Sun Y, Zhang J, Li M, et al. Oncogenic HOXB8 is driven by MYC-regulated super-enhancer and potentiates colorectal cancer invasiveness via BACH1. Oncogene. 2020;39(5):1004-17. https://doi.org/10.1038/s41388-019-1013-1.
[27] Zhang L, Wang Y, Zhang L, You G, Li C, Meng B, et al. LINC01006 promotes cell proliferation and metastasis in pancreatic cancer via miR-2682-5p/HOXB8 axis. Cancer cell international. 2019;19:320. https://doi.org/10.1186/s12935-019-1036-2.
[28] Li X, Lin H, Jiang F, Lou Y, Ji L, Li S. Knock-down of HOXB8 prohibits proliferation and migration of colorectal cancer cells via Wnt/β-catenin signaling pathway. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research. 2019;25:711-20. https://doi.org/10.12659/MSM.912218.
[29] Wang T, Lin F, Sun X, Jiang L, Mao R, Zhou S, et al. HOXB8 enhances the proliferation and metastasis of colorectal cancer cells by promoting EMT via STAT3 activation. Cancer Cell International. 2019;19:1-2. https://doi.org/10.1186/s12935-018-0717-6.
[30] Yuan W, Zhang X, Xu Y, Li S, Hu Y, Wu S. Role of HOXB7 in regulation of progression and metastasis of human lung adenocarcinoma. Molecular carcinogenesis. 2014;53(1):49-57. https://doi.org/10.1002/mc.21947.
[31] Hong Y, Kim WJ. DNA methylation markers in lung cancer. Current genomics. 2021;22(2):79-87. https://doi.org/10.2174/1389202921999201013164110.
[32] Lin YM, Taiji R, Calandri M, Odisio BC. Tumor biomarkers and interventional oncology: impact on local outcomes for liver and lung malignancy. Current oncology reports. 2021;23:67. https://doi.org/10.1007/s11912-021-01056-4.
[33] Chen J, Zhu S, Jiang N, Shang Z, Quan C, Niu Y. HoxB3 promotes prostate cancer cell progression by transactivating CDCA3. Cancer letters. 2013;330(2):217-24. https://doi.org/10.1016/j.canlet.2012.11.051.
[34] Lindblad O, Chougule RA, Moharram SA, Kabir NN, Sun J, Kazi JU, et al. The role of HOXB2 and HOXB3 in acute myeloid leukemia. Biochemical and biophysical research communications. 2015;467(4):742-7. https://doi.org/10.1016/j.bbrc.2015.10.071
International Journal of Scientific Research in Dental and Medical Sciences
Volume 6, Issue 3
Summer 2024
Pages 151-156

  • Receive Date 17 July 2024
  • Revise Date 23 August 2024
  • Accept Date 24 November 2024
  • Publish Date 01 September 2024